Please login to the form below

Not currently logged in
Email:
Password:

ABPI 'real world' value guidance

The UK's Association of the British Pharmaceutical Industry has published guidance on the use of data from real life situations to demonstrate the value of a product

The UK's Association of the British Pharmaceutical Industry (ABPI) has published guidance on the use of data from real life situations, rather than an experimental environment, to demonstrate the value of a product.

The trade organisation explained that 'real world' data is important in providing information on how patients respond to treatment in an everyday setting, and is set to become a bigger part of providing access to new medicines.

"These are challenging but exciting times in the world of healthcare and industry must be equipped to adapt and keep pace with this evolution," said ABPI medical and innovation director Dr Allison Jeynes-Ellis.

"A survey of our members showed a real appetite for guidance on how best to use real world data to prove the value of innovative new medicines – something which has always been important but is even more critical now in these tough economic times."

The guidance provides information on definitions, use and practical issues surrounding the conduct of real world data studies. How to generate real world data and a practical checklist are also included in the guide.

The ABPI has Demonstrating value with real world data available to download.

The ABPI has produced a video explaining the importance of such data, as well as how the body's guidance can be used:

24th May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...